XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:              
Net increase (decrease) in net assets resulting from operations   $ 58,183 $ 30,328 $ 152,900 $ 80,943    
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:              
Net realized (gain) loss on investments       (719) 622    
Net realized (gain) loss on foreign currency forward contracts       23 (1,739)    
Net realized (gain) loss on foreign currency and other transactions   220 10 126 (166)    
Net change in unrealized (gain) loss on investments       (15,224) 871    
Net change in unrealized (gain) loss on foreign currency forward contracts   1,786 (1,948) 105 1,211    
Net change in unrealized (gain) loss on foreign currency and other transactions   2,881 0 2,588 0    
Payment-in-kind interest capitalized       (10,010) (5,500)    
Net accretion of discounts and amortization of premiums       (7,323) (4,104)    
Purchases of investments       (1,498,871) (600,755)    
Proceeds from principal payments and sale of investments and settlement of forward contracts       400,236 105,468    
Amortization of debt issuance costs   2,508 1,578 6,733 3,831    
Changes in operating assets and liabilities:              
Interest and dividend receivable       (16,759) (15,899)    
Receivable for unsettled trades       0 (3,341)    
Other assets       96 9,092    
Interest payable       13,927 3,488    
Payable for unsettled trades       (57,455) (13,690)    
Base management fees payable       4,102 1,954    
Incentive fees payable       4,180 1,633    
Accounts payable and accrued expenses       7,518 2,434    
Directors’ fees payable       38 22    
Net cash provided by (used in) operating activities       (1,013,789) (433,625)    
Cash flows from financing activities:              
Borrowings on debt       2,147,431 850,850    
Repayments of debt       (1,512,211) (750,791)    
Proceeds from short-term borrowings       0 180,198    
Repayments of short-term borrowings       0 (112,188)    
Debt issuance costs capitalized       (13,052) (2,790)    
Proceeds from issuance of common stock       549,392 361,690    
Repurchases of common stock       (50,370) (22,320)    
Stockholder distributions paid       (74,624) (43,477)    
Net cash provided by (used in) financing activities       1,046,566 461,172    
Net increase (decrease) in cash and restricted cash and cash equivalents       32,777 27,547    
Effect of foreign currency exchange rates       16 166    
Cash and restricted cash and cash equivalents, beginning of period       77,755 52,204 $ 52,204  
Cash and restricted cash and cash equivalents, end of period $ 110,548 110,548 79,917 110,548 79,917 77,755  
Supplemental disclosure of cash flow information:              
Cash interest paid during the period       74,686 34,097    
Cash paid for income taxes, including excise taxes, during the period       586 209    
Supplemental disclosure of non-cash activities:              
Stock issued in connection with dividend reinvestment plan 21,010 21,010 10,672 54,276 26,803    
Non-cash purchases of investments       (2,100) 0    
Reconciliation of cash and restricted cash              
Cash and cash equivalents 20,357 20,357 7,563 20,357 7,563 17,586 $ 5,716
Restricted cash and cash equivalents 90,191 90,191 72,354 90,191 72,354 60,169 46,488
Total cash and restricted cash and cash equivalents shown on the Consolidated Statements of Cash Flows $ 110,548 $ 110,548 $ 79,917 $ 110,548 $ 79,917 $ 77,755 $ 52,204